Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease

被引:59
|
作者
Wills, Jonathan [1 ]
Credle, Joel [1 ]
Haggerty, Thomas [1 ]
Lee, Jae-Hoon [1 ]
Oaks, Adam W. [1 ]
Sidhu, Anita [1 ]
机构
[1] Georgetown Univ, Dept Biochem Mol & Cellular Biol, Washington, DC 20057 USA
来源
PLOS ONE | 2011年 / 6卷 / 03期
关键词
LEWY-BODY-DISEASE; ALZHEIMERS-DISEASE; TAU-PHOSPHORYLATION; NEUROFIBRILLARY TANGLES; DEMENTIA COMPLEX; BODIES; BRAIN; PATHOLOGY; MUTATION; GENE;
D O I
10.1371/journal.pone.0017953
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tauopathic pathways lead to degenerative changes in Alzheimer's disease and there is evidence that they are also involved in the neurodegenerative pathology of Parkinson's disease [PD]. We have examined tauopathic changes in striatum of the alpha-synuclein (alpha-Syn) A53T mutant mouse. Elevated levels of alpha-Syn were observed in striatum of the adult A53T alpha-Syn mice. This was accompanied by increases in hyperphosphorylated Tau [ p-Tau], phosphorylated at Ser202, Ser262 and Ser396/404, which are the same toxic sites also seen in Alzheimer's disease. There was an increase in active p-GSK-3 beta, hyperphosphorylated at Tyr216, a major and primary kinase known to phosphorylate Tau at multiple sites. The sites of hyperphosphorylation of Tau in the A53T mutant mice were similar to those seen in post-mortem striata from PD patients, attesting to their pathophysiological relevance. Increases in p-Tau were not due to alterations on protein phosphatases in either A53T mice or in human PD, suggesting lack of involvement of these proteins in tauopathy. Extraction of striata with Triton X-100 showed large increases in oligomeric forms of alpha-Syn suggesting that alpha-Syn had formed aggregates the mutant mice. In addition, increased levels of p-GSK-3 beta and pSer396/404 were also found associated with aggregated alpha-Syn. Differential solubilization to measure protein binding to cytoskeletal proteins demonstrated that p-Tau in the A53T mutant mouse were unbound to cytoskeletal proteins, consistent with dissociation of p-Tau from the microtubules upon hyperphosphorylation. Interestingly, alpha-Syn remained tightly bound to the cytoskeleton, while p-GSK-3 beta was seen in the cytoskeleton-free fractions. Immunohistochemical studies showed that alpha-Syn, pSer396/404 Tau and p-GSK-3 beta co-localized with one another and was aggregated and accumulated into large inclusion bodies, leading to cell death of Substantia nigral neurons. Together, these data demonstrate an elevated state of tauopathy in striata of the A53T alpha-Syn mutant mice, suggesting that tauopathy is a common feature of synucleinopathies.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] A53T mutant human α-synuclein BAC transgenic mice as a model for Parkinson's disease
    Taguchi, T.
    Masashi, I.
    Uemura, M.
    Hatanaka, Y.
    Uemura, N.
    Yamakado, H.
    Takahashi, R.
    MOVEMENT DISORDERS, 2018, 33 : S404 - S405
  • [2] Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease
    Deusser, Janina
    Schmidt, Stefanie
    Ettle, Benjamin
    Ploetz, Sonja
    Huber, Sabine
    Mueller, Christian P.
    Masliah, Eliezer
    Winkler, Juergen
    Kohl, Zacharias
    JOURNAL OF NEUROCHEMISTRY, 2015, 135 (03) : 589 - 597
  • [3] The Effects of Trehalose in the A53T Mouse Model of Parkinson's Disease
    Paumier, K. L.
    Rizzo, S. J. Sukoff
    Berger, Z.
    Chen, Y.
    Gonzales, C.
    Kaftan, E.
    Li, L.
    Lotarski, S.
    Shen, W.
    Stolyar, P.
    Vasilyev, D.
    Zaleska, M.
    Dunlop, J.
    Hirst, W. D.
    CELL TRANSPLANTATION, 2013, 22 (05) : 912 - 912
  • [4] Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease
    Kumar, Sonu
    Sarkar, Anita
    Sundar, Durai
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 387 (02) : 305 - 309
  • [5] Glutathione S-transferase polymorphisms and onset age in α-synuclein A53T mutant Parkinson's disease
    Golbe, Lawrence I.
    Di Iorio, Giuseppe
    Markopoulou, Katerina
    Athanassiadou, Aglaia
    Papapetropoulos, Spiridon
    Watts, Ray L.
    Vance, Jeffery M.
    Bonifati, Vincenzo
    Williams, Tanishia A.
    Spychala, John R.
    Stenroos, E. Scot
    Johnson, Williams G.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2007, 144B (02) : 254 - 258
  • [6] Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model
    Wang, Weiwei
    Song, Ning
    Jia, Fengjv
    Tang, Tingting
    Bao, Weiqi
    Zuo, Chuantao
    Xie, Junxia
    Jiang, Hong
    NEUROCHEMISTRY INTERNATIONAL, 2018, 114 : 71 - 79
  • [7] Effects of Ginkgo Biloba Extract on A53T α-Synuclein Transgenic Mouse Models of Parkinson's Disease
    Kuang, Shaosong
    Yang, Lin
    Rao, Ziliang
    Zhong, Zhiyong
    Li, Jinfeng
    Zhong, Haichao
    Dai, Lulu
    Tang, Xiaojiang
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2018, 45 (02) : 182 - 187
  • [8] Quantitative proteomics of a presymptomatic A53T α-synuclein drosophila model of Parkinson disease
    Xun, Zhiyin
    Sowell, Rena A.
    Kaufman, Thomas C.
    Clemmer, David E.
    MOLECULAR & CELLULAR PROTEOMICS, 2008, 7 (07) : 1191 - 1203
  • [9] LRRK2 pathology in sporadic and alpha-synuclein A53T mutant Parkinson's disease
    Huang, Y.
    Gai, W.
    McCann, H.
    Halliday, G.
    MOVEMENT DISORDERS, 2006, 21 : S581 - S582
  • [10] Fibrillization of α-synuclein and tau in familial Parkinson's disease caused by the A53T α-synuclein mutation
    Kotzbauer, PT
    Giasson, BI
    Kravitz, AV
    Golbe, LI
    Mark, MH
    Trojanowski, JQ
    Lee, VMY
    EXPERIMENTAL NEUROLOGY, 2004, 187 (02) : 279 - 288